Last reviewed · How we verify
Duraprep Surgical Solution — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Duraprep Surgical Solution (Duraprep Surgical Solution) — Rothman Institute Orthopaedics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Duraprep Surgical Solution TARGET | Duraprep Surgical Solution | Rothman Institute Orthopaedics | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Duraprep Surgical Solution CI watch — RSS
- Duraprep Surgical Solution CI watch — Atom
- Duraprep Surgical Solution CI watch — JSON
- Duraprep Surgical Solution alone — RSS
Cite this brief
Drug Landscape (2026). Duraprep Surgical Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/duraprep-surgical-solution. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab